Daniel Savic

4.8k total citations
26 papers, 981 citations indexed

About

Daniel Savic is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Daniel Savic has authored 26 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Public Health, Environmental and Occupational Health and 8 papers in Genetics. Recurrent topics in Daniel Savic's work include Acute Lymphoblastic Leukemia research (8 papers), Genomics and Chromatin Dynamics (8 papers) and Epigenetics and DNA Methylation (7 papers). Daniel Savic is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Genomics and Chromatin Dynamics (8 papers) and Epigenetics and DNA Methylation (7 papers). Daniel Savic collaborates with scholars based in United States, Singapore and China. Daniel Savic's co-authors include R Myers, Marcelo A. Nóbrega, E. Christopher Partridge, Noboru J. Sakabe, Jason Gertz, Graeme I. Bell, Katherine E. Varley, Timothy E. Reddy, Alexias Safi and Gregory E. Crawford and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Daniel Savic

25 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Savic United States 13 708 230 164 118 109 26 981
Michael Volkmar Germany 10 727 1.0× 165 0.7× 161 1.0× 73 0.6× 135 1.2× 18 915
Julie Moreau Canada 13 823 1.2× 80 0.3× 140 0.9× 83 0.7× 74 0.7× 19 1.1k
Dorota Piekutowska‐Abramczuk Poland 17 773 1.1× 181 0.8× 41 0.3× 86 0.7× 62 0.6× 59 1.0k
Joanna Kaczynski United States 5 968 1.4× 285 1.2× 100 0.6× 133 1.1× 45 0.4× 7 1.1k
M.Q. Islam Sweden 16 538 0.8× 273 1.2× 73 0.4× 71 0.6× 64 0.6× 46 805
Marius C. Jones United Kingdom 10 426 0.6× 166 0.7× 396 2.4× 155 1.3× 56 0.5× 10 908
Erikjan Rijkers Netherlands 13 674 1.0× 126 0.5× 70 0.4× 93 0.8× 77 0.7× 17 894
Beatriz Pérez‐Villamil Spain 16 401 0.6× 154 0.7× 94 0.6× 90 0.8× 118 1.1× 21 728
Madhurima Saxena United States 16 617 0.9× 267 1.2× 57 0.3× 96 0.8× 97 0.9× 22 1.1k
Yoh-ichi Kawabe Japan 12 659 0.9× 203 0.9× 86 0.5× 118 1.0× 42 0.4× 12 807

Countries citing papers authored by Daniel Savic

Since Specialization
Citations

This map shows the geographic impact of Daniel Savic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Savic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Savic more than expected).

Fields of papers citing papers by Daniel Savic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Savic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Savic. The network helps show where Daniel Savic may publish in the future.

Co-authorship network of co-authors of Daniel Savic

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Savic. A scholar is included among the top collaborators of Daniel Savic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Savic. Daniel Savic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishii, Rina, Hieu Vu, Kashi Raj Bhattarai, et al.. (2025). The NUDIX hydrolase NUDT5 regulates thiopurine metabolism and cytotoxicity. Journal of Clinical Investigation. 135(14). 2 indexed citations
2.
Li, Zhenhua, Kelly R. Barnett, Yizhen Li, et al.. (2024). EBF1 Activity Controls Leukemia Sensitivity to Inotuzumab Ozogamicin. Blood. 144(Supplement 1). 830–830.
3.
Barnett, Kelly R., Kashi Raj Bhattarai, Baranda S. Hansen, et al.. (2023). Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia. Blood Advances. 7(15). 4107–4111. 1 indexed citations
4.
Diedrich, Jonathan D., Yang Zhang, Kelly R. Barnett, et al.. (2022). Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemia. Leukemia. 36(10). 2374–2383. 3 indexed citations
5.
Zhao, Xujie, Ping Wang, Jonathan D. Diedrich, et al.. (2022). Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia. Nature Communications. 13(1). 5401–5401. 8 indexed citations
6.
Zhao, Xujie, Maoxiang Qian, Charnise Goodings, et al.. (2022). Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia. JNCI Journal of the National Cancer Institute. 114(9). 1287–1295. 12 indexed citations
7.
Diedrich, Jonathan D., Qian Dong, Daniel C. Ferguson, et al.. (2021). Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks. Leukemia. 35(11). 3078–3091. 10 indexed citations
8.
Barnett, Kelly R., Jonathan D. Diedrich, Wenjian Yang, et al.. (2021). Chromatin Accessibility Landscapes of Acute Lymphoblastic Leukemia. Blood. 138(Supplement 1). 2215–2215. 1 indexed citations
9.
Pham, Duy, Carson E. Moseley, Min Gao, et al.. (2019). Batf Pioneers the Reorganization of Chromatin in Developing Effector T Cells via Ets1-Dependent Recruitment of Ctcf. Cell Reports. 29(5). 1203–1220.e7. 70 indexed citations
10.
Chisolm, Danielle A., Daniel Savic, Amanda J. Moore, et al.. (2017). CCCTC-Binding Factor Translates Interleukin 2- and α-Ketoglutarate-Sensitive Metabolic Changes in T Cells into Context-Dependent Gene Programs. Immunity. 47(2). 251–267.e7. 80 indexed citations
11.
Savic, Daniel, Ryne C. Ramaker, Brian S. Roberts, et al.. (2016). Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation. Genome Medicine. 8(1). 74–74. 30 indexed citations
12.
Savic, Daniel, Brian S. Roberts, Julia B. Carleton, et al.. (2015). Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein beta binding sites. Genome Research. 25(12). 1791–1800. 25 indexed citations
13.
Savic, Daniel, E. Christopher Partridge, Kimberly M. Newberry, et al.. (2015). CETCh-seq: CRISPR epitope tagging ChIP-seq of DNA-binding proteins. Genome Research. 25(10). 1581–1589. 94 indexed citations
14.
Savic, Daniel, Mark C. Zielinski, Soo Young Park, et al.. (2014). Evidence of non-pancreatic beta cell-dependent roles of Tcf7l2 in the regulation of glucose metabolism in mice. Human Molecular Genetics. 24(6). 1646–1654. 24 indexed citations
15.
Gertz, Jason, Daniel Savic, Katherine E. Varley, et al.. (2013). Distinct Properties of Cell-Type-Specific and Shared Transcription Factor Binding Sites. Molecular Cell. 52(1). 25–36. 241 indexed citations
16.
Savic, Daniel, et al.. (2013). Mapping genome-wide transcription factor binding sites in frozen tissues. Epigenetics & Chromatin. 6(1). 30–30. 20 indexed citations
17.
Savic, Daniel, et al.. (2012). In vitro scan for enhancers at the TCF7L2 locus. Diabetologia. 56(1). 121–125. 11 indexed citations
18.
Savic, Daniel, Graeme I. Bell, & Marcelo A. Nóbrega. (2012). An in vivo cis-Regulatory Screen at the Type 2 Diabetes Associated TCF7L2 Locus Identifies Multiple Tissue-Specific Enhancers. PLoS ONE. 7(5). e36501–e36501. 14 indexed citations
19.
Savic, Daniel, Margaret G. Distler, Greta Sokoloff, et al.. (2011). Modulation of Tcf7l2 Expression Alters Behavior in Mice. PLoS ONE. 6(10). e26897–e26897. 18 indexed citations
20.
Savic, Daniel, Honggang Ye, Ivy Aneas, et al.. (2011). Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Research. 21(9). 1417–1425. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Volkmar Breakdown of academic impact, for papers by Julie Moreau Breakdown of academic impact, for papers by Dorota Piekutowska‐Abramczuk Breakdown of academic impact, for papers by Joanna Kaczynski Breakdown of academic impact, for papers by M.Q. Islam Breakdown of academic impact, for papers by Marius C. Jones Breakdown of academic impact, for papers by Erikjan Rijkers Breakdown of academic impact, for papers by Beatriz Pérez‐Villamil Breakdown of academic impact, for papers by Madhurima Saxena Breakdown of academic impact, for papers by Yoh-ichi Kawabe
Rankless by CCL
2026